Increased antibiotic duration improves survival of irrigation and debridement after revision total joint arthroplasty
Related Experiment Video
Updated: Dec 29, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Nicholas Bene1, Xing Li2, Sumon Nandi3
1Tufts University School of Medicine, Boston, MA, USA.
Background:
We sought to evaluate reoperation-free survival following I&D with modular component exchange of revision total joint arthroplasty (TJA).
Methods:
Of revision TJAs from 2004 to 2012 (n = 4,166), 30 were I&D with modular component exchange after index revision for aseptic indications. Patients with (n = 12) and without (n = 18) reoperation for infection recurrence were analyzed.
Results:
Reoperation-free survival (60% at mean 4.8 year follow-up) improved with increased duration of antibiotic therapy (p = 0.0185), with maximum benefit at 2 years.
Conclusions:
At least 2 years of antibiotic therapy should be administered after I&D with modular component exchange for acutely infected revision TJA.
Level Of Evidence:
Level III, retrospective comparative study.
Insights
For revision total joint arthroplasty (TJA) infections, a 2-year antibiotic course after debridement and implant exchange significantly improves reoperation-free survival. This strategy is crucial for managing infected revision TJA outcomes.
Area of Science:
- Orthopedic Surgery
- Infectious Disease Management
- Biomaterials Science
Background:
- Revision total joint arthroplasty (TJA) can fail due to infection, necessitating complex management.
- Debridement and Implant Exchange (I&D) with modular component exchange is a surgical option for infected revision TJA.
Purpose of the Study:
- To evaluate reoperation-free survival after I&D with modular component exchange in revision TJA.
- To determine the impact of antibiotic therapy duration on outcomes.
Main Methods:
- Retrospective comparative study of 30 revision TJA cases undergoing I&D with modular component exchange.
- Analysis of patients with and without reoperation for infection recurrence.
- Correlation of antibiotic therapy duration with reoperation-free survival.
Main Results:
- Reoperation-free survival was 60% at a mean follow-up of 4.8 years.
- Increased duration of antibiotic therapy was associated with improved reoperation-free survival (p=0.0185).
- Maximum benefit from antibiotic therapy was observed at 2 years.
Conclusions:
- A minimum of 2 years of antibiotic therapy is recommended after I&D with modular component exchange for acutely infected revision TJA.
- Optimizing antibiotic duration is critical for enhancing reoperation-free survival in these challenging cases.
Related Concept Videos
Endocarditis III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Endocarditis IV: Nursing Management
Urinary Tract Infection IV: Nursing Management
Urine Studies II: Urine Culture and Sensitivity Test

